Registration is open for OMED22 | Save your spot today!


COVID-19 regulatory updates — July 10

By AOA Staff


COVID-19 regulatory updates for the week of July 10 are below, and include news from CMS, HHS, the Dept. of the Treasury, the CDC and the NIH.

HHS extends COVID-19 testing public-private partnership

The U.S. Department of Health and Human Services (HHS) has announced an extension of its partnership with national pharmacy and grocery retail chains CVS, Rite-Aid, Walgreens, Quest (through services at Walmart) and eTrueNorth (through services at Kroger, Health Mart, and Walmart) to continue providing access to COVID-19 testing. The partnership, which is part of the Community-Based Testing Program, has scaled up to more than 600 COVID-19 testing sites in 48 states and the District of Columbia.

Five things about nursing homes during COVID-19

Hear from CMS Administrator Seema Verma about five things CMS is doing to stop the spread of coronavirus in nursing homes as part of an ongoing training webcast series. Safeguarding the health and well-being of the most vulnerable and fragile Americans is a top priority for the Trump Administration.

Detailed Paycheck Protection Program loan data released

The Small Business Administration and the Department of the Treasury released detailed loan-level data for loans made under the Paycheck Protection Program. The data includes business name, address, business type, demographic information, jobs supported and loan amount. This level of data is publicly available for loans greater than $150,000.

CDC updates and expands list of people at risk of severe COVID-19 illness

The Centers for Disease Control and Prevention (CDC) has updated and expanded the list of people at risk for getting severely ill from COVID-19 based on age and underlying medical conditions.

Experts identify steps to expand and improve antibody tests in COVID-19 response

More than 300 scientists and clinicians from the federal government, industry and academia published a report of their conclusions and recommendations on COVID-19 serology studies.  Recommendations indicate that additional research is needed to determine if and to what extent a positive antibody test means a person may be protected from reinfection with SARS-CoV-2.